Have a feature idea you'd love to see implemented?
Let us know!
STIM Neuronetics Inc
Price (delayed)
$0.8354
Market cap
$25.35M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.22
Enterprise value
$53.18M
Neuronetics, Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its commercial
Highlights
The gross profit has grown by 11% YoY and by 4.2% from the previous quarter
The revenue has grown by 5% YoY
Neuronetics's quick ratio has decreased by 31% YoY but it has increased by 12% from the previous quarter
The company's debt fell by 22% QoQ but it rose by 21% YoY
STIM's equity has dropped by 75% year-on-year and by 52% since the previous quarter
The net income has contracted by 12% from the previous quarter and by 10% YoY
Key stats
What are the main financial stats of STIM
Market
Valuations
Earnings
Shares outstanding
30.35M
Market cap
$25.35M
Enterprise value
$53.18M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.7
Price to sales (P/S)
0.35
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.73
Revenue
$72.71M
EBIT
-$29.05M
EBITDA
-$26.92M
Free cash flow
-$22.52M
Per share
Balance sheet
Liquidity
EPS
-$1.22
Free cash flow per share
-$0.74
Book value per share
$0.31
Revenue per share
$2.4
TBVPS
$2.45
Total assets
$74.12M
Total liabilities
$64.74M
Debt
$48.7M
Equity
$9.38M
Working capital
$36.56M
Debt to equity
5.19
Current ratio
3.16
Quick ratio
2.41
Net debt/EBITDA
-1.03
Margins
Efficiency
Dividend
EBITDA margin
-37%
Gross margin
75.7%
Net margin
-50.1%
Operating margin
-37.8%
Return on assets
-37.3%
Return on equity
-160.8%
Return on invested capital
-30.9%
Return on capital employed
-50.8%
Return on sales
-40%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
STIM stock price
How has the Neuronetics stock price performed over time
Intraday
4.1%
1 week
5.75%
1 month
-16.46%
1 year
-36.71%
YTD
-71.19%
QTD
9.95%
Financial performance
How have Neuronetics's revenue and profit performed over time
Revenue
$72.71M
Gross profit
$55.04M
Operating income
-$27.52M
Net income
-$36.42M
Gross margin
75.7%
Net margin
-50.1%
The company's operating margin rose by 23% YoY and by 5% QoQ
STIM's operating income is up by 19% YoY and by 4% from the previous quarter
The net income has contracted by 12% from the previous quarter and by 10% YoY
The company's net margin fell by 11% QoQ and by 4.8% YoY
Growth
What is Neuronetics's growth rate over time
Valuation
What is Neuronetics stock price valuation
P/E
N/A
P/B
2.7
P/S
0.35
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.73
STIM's EPS is down by 10% from the previous quarter and by 3.4% YoY
STIM's equity has dropped by 75% year-on-year and by 52% since the previous quarter
STIM's price to book (P/B) is 16% less than its last 4 quarters average of 3.2 but 8% more than its 5-year quarterly average of 2.5
The P/S is 83% below the 5-year quarterly average of 2.1 and 65% below the last 4 quarters average of 1.0
The revenue has grown by 5% YoY
Efficiency
How efficient is Neuronetics business performance
The ROE has plunged by 129% YoY and by 48% from the previous quarter
STIM's ROIC is up by 21% YoY but it is down by 12% from the previous quarter
The return on assets has declined by 18% since the previous quarter and by 17% year-on-year
STIM's ROS is down by 12% from the previous quarter but it is up by 2.2% YoY
Dividends
What is STIM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for STIM.
Financial health
How did Neuronetics financials performed over time
The total assets is 14% more than the total liabilities
STIM's current ratio is down by 32% YoY but it is up by 22% from the previous quarter
Neuronetics's quick ratio has decreased by 31% YoY but it has increased by 12% from the previous quarter
STIM's equity has dropped by 75% year-on-year and by 52% since the previous quarter
STIM's debt to equity has soared by 61% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.